Substance / Medication

Hydroxychloroquine

Overview

Active Ingredient
hydroxychloroquine
RxNorm CUI
5521

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

30 trials linked to this intervention

30
Total Trials
8
Recruiting
7
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Psychiatric Adverse Effects From Hydroxychloroquine Use: A Systematic Review.
Setty Madhuri Jakkam, Kavi Ramananda Kishore, Sulthana Parveen et al. · Prim Care Companion CNS Disord · 2025
PMID: 40446824Meta-Analysis
Role of hydroxychloroquine in primary glomerular disease - a systematic review and meta-analysis of the current evidence.
Mathew Gerry George, Sundaramurthy Shanmugam, Muthuperumal Prakash et al. · BMC Nephrol · 2025
PMID: 40759913Meta-AnalysisFull text (PMC)
Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis.
Zhu Qingmiao, Wang Jiayu, Sun Qice et al. · Lupus Sci Med · 2024
PMID: 39477333Meta-AnalysisFull text (PMC)
Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review.
Garcia Michael Cristian, Tsang Kai La, Lohit Simran et al. · Ann Pharmacother · 2024
PMID: 37881891Meta-AnalysisFull text (PMC)
Hydroxychloroquine and COVID-19 story: is the low-dose treatment the missing link? A comprehensive review and meta-analysis.
Ramdani Idir, Bouazza Belaid · Naunyn Schmiedebergs Arch Pharmacol · 2024
PMID: 37639021Meta-Analysis
Efficacy and Safety of Hydroxychloroquine in Patients with IgA Nephropathy: A Meta-Analysis.
Zhang Zhe, Liu Xiaoyi, Ye Peiyi et al. · Arch Esp Urol · 2024
PMID: 38374008Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Hydroxychloroquine (substance)
SNOMED CT
373540008
UMLS CUI
C0020336
RxNorm CUI
5521

Clinical Data

This intervention maps to 15 entities in the Healos knowledge graph.

7
Conditions
4
Biomarkers
2
Specialists
0
Symptoms
30
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.